A wonder drug called Rapamycin that a wealthy man named Bryan Johnson was testing on himself for longevity may have turned out to be a dud. Or at least he has given up on it.
Manu Joseph: There’s crushing news for people who want to live long
Related Posts
Blue Water Logistics sets IPO price band at Rs 132–135 per share; issue opens May 27
Blue Water Logistics has set the IPO price band at Rs 132–135 per share, aiming to raise Rs 40.5 crore through a fresh issue of shares. Opening on May 27…
Read moreJNU PG Admission 2025: Registration begins via CUET PG, GAT-B, and CCMT, apply by this date
Jawaharlal Nehru University has opened postgraduate admissions for the 2025 academic year, accepting applications until June 16, 2025. Admissions will be based on CUET PG 2025, GAT-B, and CCMT (GATE…
Read more